RSV has been a scary diagnosis for years, but now there is hope with a new FDA approved vaccine. It was approved on May 3 for people over the age of 60. The vaccine was developed by Glaxo Smith Kline and is known as Arexvy. Veuer’s Keri Lumm has more.
